{
  "trial_id": "NCT01478594",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, ECOG performance status, baseline tumor measurements, prior adjuvant therapy, hemoglobin levels, absolute neutrophil count, platelet count, prothrombin time, partial thromboplastin time, total bilirubin, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, serum albumin, creatinine, proteinuria, cardiovascular history, thromboembolic history, surgical history, gastrointestinal history, infection history, bleeding disorder history, second primary malignancy history, allergy history, pregnancy status, HIV status, neuro-psychiatric status, peripheral neuropathy status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Lactate dehydrogenase (LDH) Status",
        "Origin of Cancer",
        "Number of metastatic sites/organs",
        "Kirsten rat sarcoma (KRAS) Mutation Status",
        "Time Since Initial Diagnosis",
        "Number of metastatic sites at screening"
      ],
      "remaining_candidate_features": [
        "race",
        "baseline tumor measurements",
        "prior adjuvant therapy",
        "hemoglobin levels",
        "absolute neutrophil count",
        "platelet count",
        "prothrombin time",
        "partial thromboplastin time",
        "total bilirubin",
        "aspartate aminotransferase",
        "alanine aminotransferase",
        "alkaline phosphatase",
        "serum albumin",
        "creatinine",
        "proteinuria",
        "cardiovascular history",
        "thromboembolic history",
        "surgical history",
        "gastrointestinal history",
        "infection history",
        "bleeding disorder history",
        "second primary malignancy history",
        "allergy history",
        "pregnancy status",
        "HIV status",
        "neuro-psychiatric status",
        "peripheral neuropathy status"
      ]
    },
    "processed-gen-response": "Age, sex, race, ECOG performance status, baseline tumor measurements, prior adjuvant therapy, hemoglobin levels, absolute neutrophil count, platelet count, prothrombin time, partial thromboplastin time, total bilirubin, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, serum albumin, creatinine, proteinuria, cardiovascular history, thromboembolic history, surgical history, gastrointestinal history, infection history, bleeding disorder history, second primary malignancy history, allergy history, pregnancy status, HIV status, neuro-psychiatric status, peripheral neuropathy status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, ECOG Performance Status, Hemoglobin, Absolute Neutrophil Count (ANC), Platelet Count, Prothrombin Time (PT), Partial Thromboplastin Time (PTT), Total Bilirubin, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphatase, Serum Albumin, Creatinine, Proteinuria, History of Cardiovascular Disease, History of Thromboembolic or Vascular Disorders, History of Gastrointestinal (GI) Toxicity, History of Serious/Active Infection, History of Significant Bleeding Disorders, History of Second Primary Malignancy, History of Allergic Reactions, Peripheral Neuropathy Grade,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment",
        "Lactate dehydrogenase (LDH) Status",
        "Origin of Cancer",
        "Number of metastatic sites/organs",
        "Kirsten rat sarcoma (KRAS) Mutation Status",
        "Time Since Initial Diagnosis",
        "Number of metastatic sites at screening"
      ],
      "remaining_candidate_features": [
        "Hemoglobin",
        "Absolute Neutrophil Count (ANC)",
        "Platelet Count",
        "Prothrombin Time (PT)",
        "Partial Thromboplastin Time (PTT)",
        "Total Bilirubin",
        "Aspartate Aminotransferase (AST)",
        "Alanine Aminotransferase (ALT)",
        "Alkaline Phosphatase",
        "Serum Albumin",
        "Creatinine",
        "Proteinuria",
        "History of Cardiovascular Disease",
        "History of Thromboembolic or Vascular Disorders",
        "History of Gastrointestinal (GI) Toxicity",
        "History of Serious/Active Infection",
        "History of Significant Bleeding Disorders",
        "History of Second Primary Malignancy",
        "History of Allergic Reactions",
        "Peripheral Neuropathy Grade"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, ECOG Performance Status, Hemoglobin, Absolute Neutrophil Count (ANC), Platelet Count, Prothrombin Time (PT), Partial Thromboplastin Time (PTT), Total Bilirubin, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Alkaline Phosphatase, Serum Albumin, Creatinine, Proteinuria, History of Cardiovascular Disease, History of Thromboembolic or Vascular Disorders, History of Gastrointestinal (GI) Toxicity, History of Serious/Active Infection, History of Significant Bleeding Disorders, History of Second Primary Malignancy, History of Allergic Reactions, Peripheral Neuropathy Grade"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Number of Metastatic Sites, Prior Adjuvant Chemotherapy, Prior Radiotherapy, Time from Diagnosis to Metastasis, Baseline Hemoglobin, Baseline Absolute Neutrophil Count, Baseline Platelet Count, Baseline Serum Creatinine, Baseline Serum Albumin, Baseline Total Bilirubin, Baseline Aspartate Aminotransferase, Baseline Alanine Aminotransferase, Baseline Alkaline Phosphatase.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "ECOG Performance Status"
        ],
        [
          "Number of metastatic sites/organs",
          "Number of Metastatic Sites"
        ],
        [
          "Time Since Initial Diagnosis",
          "Time from Diagnosis to Metastasis"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Lactate dehydrogenase (LDH) Status",
        "Origin of Cancer",
        "Kirsten rat sarcoma (KRAS) Mutation Status",
        "Number of metastatic sites at screening"
      ],
      "remaining_candidate_features": [
        "Prior Adjuvant Chemotherapy",
        "Prior Radiotherapy",
        "Baseline Hemoglobin",
        "Baseline Absolute Neutrophil Count",
        "Baseline Platelet Count",
        "Baseline Serum Creatinine",
        "Baseline Serum Albumin",
        "Baseline Total Bilirubin",
        "Baseline Aspartate Aminotransferase",
        "Baseline Alanine Aminotransferase",
        "Baseline Alkaline Phosphatase"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Number of Metastatic Sites, Prior Adjuvant Chemotherapy, Prior Radiotherapy, Time from Diagnosis to Metastasis, Baseline Hemoglobin, Baseline Absolute Neutrophil Count, Baseline Platelet Count, Baseline Serum Creatinine, Baseline Serum Albumin, Baseline Total Bilirubin, Baseline Aspartate Aminotransferase, Baseline Alanine Aminotransferase, Baseline Alkaline Phosphatase."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG status, number and location of metastatic lesions, prior adjuvant therapy, time since diagnosis of metastatic disease, hemoglobin, absolute neutrophil count, platelet count, prothrombin time, partial thromboplastin time, total bilirubin, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, serum albumin, creatinine, proteinuria, history of cardiovascular disease, history of thromboembolic or vascular disorders.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "ECOG status"
        ],
        [
          "Number of metastatic sites/organs",
          "number and location of metastatic lesions"
        ],
        [
          "Time Since Initial Diagnosis",
          "time since diagnosis of metastatic disease"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Lactate dehydrogenase (LDH) Status",
        "Origin of Cancer",
        "Kirsten rat sarcoma (KRAS) Mutation Status",
        "Number of metastatic sites at screening"
      ],
      "remaining_candidate_features": [
        "prior adjuvant therapy",
        "hemoglobin",
        "absolute neutrophil count",
        "platelet count",
        "prothrombin time",
        "partial thromboplastin time",
        "total bilirubin",
        "aspartate aminotransferase",
        "alanine aminotransferase",
        "alkaline phosphatase",
        "serum albumin",
        "creatinine",
        "proteinuria",
        "history of cardiovascular disease",
        "history of thromboembolic or vascular disorders."
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, ECOG status, number and location of metastatic lesions, prior adjuvant therapy, time since diagnosis of metastatic disease, hemoglobin, absolute neutrophil count, platelet count, prothrombin time, partial thromboplastin time, total bilirubin, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, serum albumin, creatinine, proteinuria, history of cardiovascular disease, history of thromboembolic or vascular disorders."
  }
}